Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus

Journal of Virology

Volumn 74, Issue 8, 2000, Pages 3605-3612

  Xing, Zheng ^a,b   Schat, Karel A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CELL CULTURE; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FIBROBLAST CULTURE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VIRUS REPLICATION;

AGING; ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; FIBROBLASTS; HERPESVIRIDAE; HERPESVIRUS 2, GALLID; INTERFERON-GAMMA, RECOMBINANT; LIPOPOLYSACCHARIDES; MAREK DISEASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENICILLAMINE; POULTRY DISEASES; SPLEEN; TURKEYS; VIRUS REPLICATION;

EID: 0034108829     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.8.3605-3612.2000     Document Type: Article

References (60)

1. Albina, J. E., J. A. Abate, and W. L. Henry, Jr. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-γ in the induction of the nitric oxide synthesizing pathway. J. Immunol. 147:144-148.
2. Alspaugh, J. A., and D. L. Granger. 1991. Inhihition of Cryptococcus neoformans replication hy nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59:2291-2296.
3. Bredt, D. S., and S. H. Snyder. 1992. Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
4. Buckmaster, A. E., S. D. Scott, M. J. Sanderson, M. E. G. Boursnell, L. J. N. Ross, and M. M. Binns. 1988. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys - implications for herpesvirus classification. J. Gen. Virol. 69:2033-2042.
5. Buscaglia, C., and B. W. Calnek. 1988. Maintenance of Marek's disease herpesvirus latency in vitro by a factor found in conditioned medium. J. Gen. Virol. 69:2809-2818.
6. Calnek, B. W. 1986. Marek's disease - a model for herpesvirus oncology. Crit. Rev. Microbiol. 12:293-320.
7. Calnek, B. W., D. F. Adene, K. A. Schat, and H. Abplanalp. 1989. Immune responsiveness versus susceptibility to Marek's disease. Poul. Sci. 68:17-26.
8. Calnek, B. W., J. C. Carlisle, J. Fabricant, K. K. Murthy, and K. A. Schat. 1979. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Am. J. Vet. Res. 40:541-548.
9. Calnek, B. W., K. A. Schat, E. D. Heller, and C. Buscaglia. 1985. In vitro infection of T lymphocytes with Marek's disease virus, p 173-187. In B. W. Calnek and J. L. Spencer (ed.), International Symposium on Marek's disease. American Association of Avian Pathologists, Kennett Square, Pa.
10. Calnek, B. W., and R. L. Witter. 1997. Marek's disease p. 369-413. In B. W. Calnek, H. J. Barnes, C. W. Beard, L. R. McDougald, and Y. M. Saif. (ed.), Diseases of poultry, 10th ed. Iowa State University Press, Ames, Iowa.
11. Cole, R. K. 1968. Studies on genetic resistance to Marek's disease. Avian Dis. 12:9-28.
12. Colton, T. 1974. Statistics in medicine. Little, Brown and Company, Boston, Mass.
13. Croen, K. D. 1993. Evidence for an antiviral effect of nitric oxide: inhibition of herpes simplex virus type 1 replication. J. Clin. Investig. 91:2446-2452.
14. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150-157.
15. Digby, M. R., and J. W. Lowenthal. 1995. Cloning and expression of the chicken interferon-gamma gene. J. Interferon Cytokine Res. 15:939-945.
16. Esumi, H., and S. R. Tannenbaum. 1994. U.S.-Japan Cooperative Cancer Research Program: seminar on nitric oxide synthase and carcinogenesis. Cancer Res. 54:297-301.
17. Fecho, K., K. A. Maslonek, M. E. Coussons-Read, L. A. Dykstra, and D. T. Lysle. 1994. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152:5845-5852.
18. Granger, D. L., J. B. Hibbs, J. R. Perfect, and D. T. Durack. 1988. Specific amino acid (L-arginine) requirement for the microhiostatic activity of murine macrophages. J. Clin. Investig. 81:1129-1136.
19. Gupta, M. K., H. V. S. Chauhan, G. J. Jha, and K. K. Singh. 1989. The role of the reticuloendothelial system in the immunopathology of Marek's disease. Vet. Microbiol. 20:223-234.
20. Haffer, K., M. Sevoian, and M. Wilder. 1979. The role of the macrophages in Marek's disease: in vitro and in vivo studies. Int. J. Cancer 23:648-656.
21. Higgins, D. A., and B. W. Calnek. 1976. Some effects of silica treatment on Marek's disease. Infect. Immun. 13:1054-1060.
22. Hussain, I., and M. A. Qureshi. 1998. The expression and regulation of inducible nitric oxide synthase gene differ in macrophages from chickens of different genetic background. Vet. Immunol. Immunopathol. 61:317-329.
23. James, S. L., and J. Glavin. 1989. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208-4212.
24. Jeurissen, S. H. M., and E. M. Janse. 1989. Distribution and function of non-lymphoid cells in liver and spleen of embryonic and adult chickens, p. 149-157. In B. S. Bhogal and G. Koch (ed.), Recent advances in avian immunology research. Alan R. Liss, New York, N.Y.
25. Karupiah, G., Q. W. Xie, R. Mark, L. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445-1448.
26. Kim, I. J., K. Karaca, T. L. Pertile, S. A. Erickson, and J. M. Sharma. 1998. Enhanced expression of cytokine genes in spleen macrophages during acute infection with infectious bursal disease virus in chickens. Vet. Immunol. Immunopathol. 61:331-341.
27. Kodama, H., T. Mikami, M. Inoue, and H. Izawa. 1979. Inhibitory effects of macrophages against Marek's disease virus plaque formation in chicken kidney cell cultures. J. Natl. Cancer Inst. 63:1267-1271.
28. Kwon, N. S., D. J. Stuehr, and C. F. Nathan. 1991. Inhibition of tumor cell ribonucleotide reductase by macrophage derived nitric oxide. J. Exp. Med. 174:761-768.
29. Lee, L. F. 1979. Macrophage restriction of Marek's disease virus replication and lymphoma cell proliferation. J. Immunol. 123:1088-1091.
30. Lee, L. F., J. M. Sharma, K. Nazerian, and R. L. Witter. 1978. Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkey. Infect. Immun. 21:474-479.
31. Lee, L. F., J. M. Sharma, K. Nazerian, and R. L. Witter. 1978. Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus. J. Immunol. 120:1554-1559.
32. Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fontecave. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:442-448.
33. Liew, F. Y., S. Millott, C. Parkison, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
34. Lin, A. W., C. C. Chang, and C. C. McCormick. 1996. Molecular cloning and expression of an avian macrophage nitric oxide synthase cDNA and the analysis of the genomic 5′-flanking region. J. Biol. Chem. 271:11911-11919.
35. Lowenstein, C. J., S. L. Hill, A. Lafond-Walker, J. Wu, G. Allen, M. Landavere, N. R. Rose, and A. Herskowitz. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Investig. 97:1837-1843.
36. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137-1146.
37. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
38. Nathan, C. F., and J. B. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
39. Nguyen, T., D. Brunson, C. L. Crespi, B. W. Penman, J. S. Wishnok, and S. R. Tannenbaum. 1992. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89:3030-3034.
40. Omar, A. R., and K. A. Schat. 1996. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late and unique MDV proteins. Virology 222:87-99.
41. Pertile, T. L., J. M. Sharma, and M. M. Walser. 1995. Reovirus infection in chickens primes splenic adherent macrophages to produce nitric oxide in response to T cell-produced factors. Cell. Immunol. 164:207-216.
42. Powell, P. C., K. J. Hartley, B. M. Mustill, and M. Rennie. 1983. Studies on the role of macrophages in Marek's disease of the chicken. J. Reticuloendothel. Soc. 34:289-297.
43. Rice, W. G., C. A. Schaeffer, B. Harten, F. Villinger, T. L. South, M. F. Summers, L. E. Henderson, J. W. Bess, Jr., L. O. Arthur, and J. S. McDougal. 1993. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature (London) 361:473-475.
44. Samuel, C. E. 1991. Antiviral actions of interferons: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11.
45. Schat, K. A. 1985. Characterization of the virus, p. 77-102. In L. N. Payne (ed.), Marek's disease: scientific basis and methods of control. Martinus Nijhoff Publishing, Boston, Mass.
46. Schat, K. A. 1987. Marek's disease - a model for protection against herpesvirus-induced tumors. Cancer Surv. 6:1-37.
47. Schat, K. A., and B. W. Calnek. 1978. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1075-1082.
48. Schat, K, A., B. W. Calnek, J. Fabricant, and D. L. Graham. 1985. Pathogenesis of infection with attenuated Marek's disease virus strains. Avian Pathol. 14:127-146.
49. Schat, K. A., C.-L. H. Chen, B. W. Calnek, and D. Char. 1991. Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J. Virol. 65: 1408-1413.
50. Schat, K. A., and C. Davies. 2000. Resistance to viral diseases, p. 271-300. In R.F.E. Axford, J. B. Owen, and F. Nicholas (ed.), Breeding for disease resistance in farm animals, 2nd ed. CAB International, Wallingford, United Kingdom.
51. Schat, K. A., and H. G. Purchase. 1998. Cell-culture methods, p. 223-234. In D. E. Swayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, and W. M. Reed (ed.), A laboratory manual for the isolation and identification of avian pathogens, 4th ed. American Association of Avian Pathologists, Kennett Square, Pa.
52. Schat, K. A., R. D. Schultz, and B. W. Calnek. 1978. Marek's disease: effect of virus pathogenicity and genetic susceptibility on response of peripheral blood lymphocytes to concanavalin-A, p. 183-185. In P. Bentvelzen, J. Hilgers, and D. S. Yohn (ed.), Advances in comparative leukosis research. Elsevier, Amsterdam, The Netherlands.
53. Sekellick, M. J., A. F. Ferrandino, D. A. Hopkins, and P. I. Marcus. 1994. Chicken interferon gene: cloning, expression, and analysis. J. Interferon Res. 14:71-79.
54. Swinscow, T. D. V. 1980. Statistics at Square One. British Medical Association, London, and Dawson & Goodall, Ltd., The Mendip Press, Bath, United Kingdom.
55. Tay, C. H., and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.
56. Volpini, L. M., B. W. Calnek, M. J. Sekellick, and P. I. Marcus. 1995. Stages of Marek's disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression. Vet. Microbiol. 47:99-109.
57. Weinstack, D., and K. A. Schat. 1987. Virus specific syngeneic killing of reticuloendotheliosis virus transformed cell line target cells by spleen cells. Prog. Clin. Biol. Res. 238:253-263.
58. Wink, D. A., K. S. Kasprzak, C. M. Maragos, R. K. Elespuru, M. Misra, T. M. Dunams, T. A. Cebula, W. H. Koch, A. W. Andrews, and J. S. Allen. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001-1003.
59. Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. 1970. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:525-538.
60. Xing, Z., and K. A. Schat. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology, in press.